REGULATORY AFFAIRS SPECIALIST – AFRICA & MENA

Atome Pharma GroupDubaigulftalentavaldatud 10.09.2026
Nõutav:QA/Test

KEY RESPONSIBILITIES

  • Develop regulatory strategies and manage product registrations, renewals and variations across Africa and MENA.
  • Prepare, review and coordinate CTD/eCTD and country-specific regulatory dossiers.
  • Coordinate with manufacturers to obtain and review required documents, including GMP, CPP, FSC, DMF/CEP, CoA, specifications, stability data and manufacturing licences.
  • Manage regulatory submissions, authority queries, deficiency letters and responses through to approval.
  • Maintain an updated regulatory tracker covering submissions, approvals, renewals, variations and regulatory commitments.
  • Liaise with National Regulatory Authorities, local agents and regulatory consultants.
  • Support product selection and new market expansion by providing regulatory feasibility and requirements.
  • Monitor regulatory changes in Africa and MENA and advise relevant internal teams.
  • Work closely with QA, Business Development, Procurement and manufacturers to ensure timely and compliant submissions.
  • Ensure regulatory documentation is properly maintained and activities are completed within agreed timelines.
  • 5–10+ years of Regulatory Affairs experience in pharmaceuticals and/or medical devices.
  • Proven hands-on experience with Africa and MENA regulatory submissions and registrations.
  • Good knowledge of Francophone and/or Anglophone African markets.
  • Strong experience in CTD/eCTD dossiers, renewals, variations and regulatory queries.
  • Good understanding of GMP and pharmaceutical regulatory documentation.
  • Experience coordinating with manufacturers, regulatory authorities, agents and consultants.
  • Strong attention to detail, organisational and project-management skills.
  • Ability to manage multiple countries, products and deadlines independently.
  • Fluent English required; French is highly desirable.
  • Willingness to travel internationally when required.